alzheimer semaglutide Weight Loss Drug Shows Promise as Alzheimer's Treatment : ScienceAlert Semaglutide may reduce Alzheimer's risk
Description
[DOI] [PubMed] [Google Scholar] 23.McGuinness, L.A

The results revealed that the expression of MYH7 and ANP were significantly elevated in TAC group, compared to the Sham group, but their expression in the TAC + semaglutide group were markedly reduced, compare to the TAC group, by Western blot and IHC respectively

MMHE-44K)

heart and kidney) protection are complementary and not mutually exclusive, clinicians should not confuse the discussion of choice of agents for their glucose-lowering effect with the discussion of choice of specific agents for their direct organ-protecting effect

For more structure around treatment habits, see our GLP-1 medication checklist for getting started
